Amphotericin: Confusion between non-lipid and lipid formulations
admin September 3rd, 2007
The National Patient Safety Agency (NPSA) has issued a rapid response report Risk of confusion between non-lipid and lipid formulations of injectable amphotericin.
The National Patient Safety Agency (NPSA) is alerting all healthcare staff involved in the use of intravenous amphotericin of the potentially lethal results if non-lipid and lipid formulations of the drug are confused. These different formulations are used for the treatment of systemic fungal infections. The NPSA is aware of two recent deaths and a number of near misses reported to the National Reporting and Learning System (NRLS) and other similar incidents internationally.